Shalabi, O.; Kashat, L.; Murik, O.; Zevin, S.; Assous, M.V.; Ben-Chetrit, E.
Clinical Outcomes of Patients with AmpC-Beta-Lactamase-Producing Enterobacterales Bacteremia Treated with Carbapenems versus Non-Carbapenem Regimens: A Single-Center Study. Antibiotics 2024, 13, 709.
https://doi.org/10.3390/antibiotics13080709
AMA Style
Shalabi O, Kashat L, Murik O, Zevin S, Assous MV, Ben-Chetrit E.
Clinical Outcomes of Patients with AmpC-Beta-Lactamase-Producing Enterobacterales Bacteremia Treated with Carbapenems versus Non-Carbapenem Regimens: A Single-Center Study. Antibiotics. 2024; 13(8):709.
https://doi.org/10.3390/antibiotics13080709
Chicago/Turabian Style
Shalabi, Orjowan, Livnat Kashat, Omer Murik, Shoshana Zevin, Marc V. Assous, and Eli Ben-Chetrit.
2024. "Clinical Outcomes of Patients with AmpC-Beta-Lactamase-Producing Enterobacterales Bacteremia Treated with Carbapenems versus Non-Carbapenem Regimens: A Single-Center Study" Antibiotics 13, no. 8: 709.
https://doi.org/10.3390/antibiotics13080709
APA Style
Shalabi, O., Kashat, L., Murik, O., Zevin, S., Assous, M. V., & Ben-Chetrit, E.
(2024). Clinical Outcomes of Patients with AmpC-Beta-Lactamase-Producing Enterobacterales Bacteremia Treated with Carbapenems versus Non-Carbapenem Regimens: A Single-Center Study. Antibiotics, 13(8), 709.
https://doi.org/10.3390/antibiotics13080709
